Trials / Completed
CompletedNCT01436903
Chances for Success of CavatermTM Surgery as a Function of Uterus Probe Length
Chances for Success of CavatermTM Surgery as a Function of Uterus Probe Length, a Questionnaire Investigation on 290 Patients
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 290 (actual)
- Sponsor
- Medical University of Vienna · Academic / Other
- Sex
- Female
- Age
- 30 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
CavatermTM is a second-generation thermal balloon ablation device in the management of menorrhagia. The purpose of this study is to investigate the success (questionnaire) of CavatermTM dependent on uterus probe length, especially corpus probe length, which is measured during surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Thermal Balloon Endometrial Ablation | Thermal Balloon Endometrial Ablation for 10 minutes after curettage |
Timeline
- Start date
- 2010-09-01
- Primary completion
- 2011-04-01
- Completion
- 2011-04-01
- First posted
- 2011-09-20
- Last updated
- 2013-03-08
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT01436903. Inclusion in this directory is not an endorsement.